Trials / Conditions / HER2-positive Bladder Cancer
HER2-positive Bladder Cancer
3 registered clinical trials studyying HER2-positive Bladder Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871 | Iambic Therapeutics, Inc | Phase 1 |
| Completed | PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors NCT03650348 | Pieris Pharmaceuticals, Inc. | Phase 1 |
| Completed | PRS-343 in HER2-Positive Solid Tumors NCT03330561 | Pieris Pharmaceuticals, Inc. | Phase 1 |